These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


514 related items for PubMed ID: 16521631

  • 1. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group.
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F.
    N Engl J Med; 1997 Aug 14; 337(7):447-52. PubMed ID: 9250846
    [Abstract] [Full Text] [Related]

  • 4. A meta-analysis of controlled clinical trials comparing low-molecular weight heparins with unfractionated heparin in unstable angina.
    Malhotra S, Karan RS, Bhargava VK, Pandhi P, Grover A, Sharma YP, Kumar R.
    Indian Heart J; 2001 Aug 14; 53(2):197-202. PubMed ID: 11428477
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of the antithrombotlic effect and safety between intravenous nadroparin and unfractionated heparin in patients undergoing percutaneous coronary intervention].
    Zhu JH, Qiu YG, Chen JZ, Zhang FR, Fu GS, Shen FR, Huang WJ, Wang JA, Zhao LL, Tao QM, Zheng LR.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr 14; 33(4):335-9. PubMed ID: 15932664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A, Casilli F, Assanelli E, Grazi M, Marenzi G, Guazzi MD.
    Thromb Haemost; 2001 Oct 14; 86(4):991-4. PubMed ID: 11686357
    [Abstract] [Full Text] [Related]

  • 9. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.
    Wang XK, Zhang Y, Yang CM, Wang Y, Liu GY.
    Clin Drug Investig; 2006 Oct 14; 26(6):341-9. PubMed ID: 17163268
    [Abstract] [Full Text] [Related]

  • 10. Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study.
    Ageno W, Cattaneo R, Manfredi E, Chelazzi P, Venco L, Ghirarduzzi A, Cimino L, Filippucci E, Ricci AL, Romanelli D, Incorvaia C, D'Angelo S, Campana F, Molfino F, Scannapieco G, Rubbi F, Imberti D.
    Thromb Res; 2010 Feb 14; 125(2):137-41. PubMed ID: 19477488
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P, Carnovali M, Marchiori A, Galilei Investigators.
    Arch Intern Med; 2004 May 24; 164(10):1077-83. PubMed ID: 15159264
    [Abstract] [Full Text] [Related]

  • 13. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep 24; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The role of low-molecular-weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplasty].
    Cláudio Correia LC, Neubauer C, Azevedo A, Ribeiro F, Braga J, Carlos Passos L, Teixeira M, Matos M, Aires V, Souza V.
    Arq Bras Cardiol; 1995 Dec 24; 65(6):475-8. PubMed ID: 8731298
    [Abstract] [Full Text] [Related]

  • 16. Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
    Rădoi M, Bobescu E, Agache I.
    Rom J Intern Med; 2003 Dec 24; 41(3):237-46. PubMed ID: 15526507
    [Abstract] [Full Text] [Related]

  • 17. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
    Vejar M, Hackett D, Brunelli C, Spallarossa P, Ianetti M, Galassi AR, Lipkin D, Caponnetto S, Patrono C, Maseri A.
    Circulation; 1990 Jan 24; 81(1 Suppl):I4-11; discussion I22-3. PubMed ID: 2403867
    [Abstract] [Full Text] [Related]

  • 18. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
    Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie AG, van der Meer J, Olaisson E, Undeland S, Ludwig K.
    Circulation; 1997 Jul 01; 96(1):61-8. PubMed ID: 9236418
    [Abstract] [Full Text] [Related]

  • 19. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
    Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G.
    Arch Intern Med; 2007 Dec 10; 167(22):2423-30. PubMed ID: 18071163
    [Abstract] [Full Text] [Related]

  • 20. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
    Baird SH, Menown IB, Mcbride SJ, Trouton TG, Wilson C.
    Eur Heart J; 2002 Apr 10; 23(8):627-32. PubMed ID: 11969277
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.